Collaborations & Alliances
Filter by:
421 - 435 of 1387 results
December 7, 2012
Will serve as exclusive commercial supplier for U.S. market
Read More »
December 6, 2012
Will identify antibodies using ProMIS technology
Read More »
December 6, 2012
Will supply ABA product from Rensselaer facility
Read More »
December 3, 2012
Will use OmniRat platform to generate human antibodies
Read More »
December 3, 2012
To use Transcend technology for drug delivery to the brain
Read More »
November 30, 2012
To develop nanotherapeutics targeting cancers and eye diseases
Read More »
November 30, 2012
Will work to include jet injectors as delivery method for Afluria label
Read More »
November 29, 2012
To develop a commercial process for flu vaccine production
Read More »
November 28, 2012
Will leverage Selecta’s SVP platform for allergy indications
Read More »
November 28, 2012
Will validate assays to support clinical trials
Read More »
November 28, 2012
Aims to overcome poor bioavailability
Read More »
November 28, 2012
Aims to expand applications for high-performance LC-MS systems
Read More »
November 27, 2012
Peptelligence used for oral formulation of TXA127
Read More »
421 - 435 of 1387 results
